These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2157144)

  • 21. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
    Morris KM; Aden DP; Knowles BB; Colten HR
    J Clin Invest; 1982 Oct; 70(4):906-13. PubMed ID: 6288774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.
    Cai S; Davis AE
    J Immunol; 2003 Nov; 171(9):4786-91. PubMed ID: 14568956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C1-inhibitor-serine proteinase complexes and the biosynthesis of C1-inhibitor by Hep G2 and U 937 cells.
    Patston PA; Medcalf RL; Kourteva Y; Schapira M
    Blood; 1993 Dec; 82(11):3371-9. PubMed ID: 8241507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroepiandrosterone modulates the spontaneous and IL-6 stimulated fibrinogen production of human hepatoma cells.
    Fehér KG; Rákász E; Bíró J; Falus A
    Acta Microbiol Immunol Hung; 1995; 42(2):229-33. PubMed ID: 7551718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement C1-inhibitor expression in Alzheimer's disease.
    Veerhuis R; Janssen I; Hoozemans JJ; De Groot CJ; Hack CE; Eikelenboom P
    Acta Neuropathol; 1998 Sep; 96(3):287-96. PubMed ID: 9754962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of synthesis of complement proteins in HEp2 cells.
    Katz Y; Guterman M; Lahat E
    Clin Immunol Immunopathol; 1993 May; 67(2):117-23. PubMed ID: 8519088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanisms of DHEA and DHEAs on apoptosis and cell cycle arrest via Akt pathway in hepatoma cell lines].
    Jiang YF; Zhao PW; Tan Y; Liu LH; Li MH; Matsuzaki Y; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):441-4. PubMed ID: 17594810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of C1 inhibitor synthesis.
    Prada AE; Zahedi K; Davis AE
    Immunobiology; 1998 Aug; 199(2):377-88. PubMed ID: 9777421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines.
    Falus A; Kramer J; Walcz E; Varga Z; Setalo J; Jobst K; Lakatos T; Merétey K
    Immunology; 1989 Sep; 68(1):133-6. PubMed ID: 2553583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors.
    Anagnostopoulou V; Pediaditakis I; Alkahtani S; Alarifi SA; Schmidt EM; Lang F; Gravanis A; Charalampopoulos I; Stournaras C
    Endocrinology; 2013 Jul; 154(7):2446-56. PubMed ID: 23696568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937.
    Randazzo BP; Dattwyler RJ; Kaplan AP; Ghebrehiwet B
    J Immunol; 1985 Aug; 135(2):1313-9. PubMed ID: 4008925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency.
    Lappin DF; McPhaden AR; Yap PL; Carter PE; Birnie GD; Fothergill JE; Whaley K
    Eur J Clin Invest; 1989 Feb; 19(1):45-52. PubMed ID: 2499461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and regulation of the fourth component of complement (C4) in the human monocytic cell line U937: comparison with that of the third component of complement (C3).
    Tsukamoto H; Nagasawa K; Yoshizawa S; Tada Y; Ueda A; Ueda Y; Niho Y
    Immunology; 1992 Apr; 75(4):565-9. PubMed ID: 1592431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits.
    van Veen HA; Koiter J; Vogelezang CJ; van Wessel N; van Dam T; Velterop I; van Houdt K; Kupers L; Horbach D; Salaheddine M; Nuijens JH; Mannesse ML
    J Biotechnol; 2012 Dec; 162(2-3):319-26. PubMed ID: 22995741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures.
    Breitner S; Störkel S; Reichel W; Loos M
    Arthritis Rheum; 1995 Apr; 38(4):492-8. PubMed ID: 7718002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.
    Wang T; Secombes CJ
    Immunogenetics; 2003 Dec; 55(9):615-28. PubMed ID: 14628103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autocrine secretion of tumor necrosis factor under the influence of interferon-gamma amplifies HLA-DR gene induction in human monocytes.
    Arenzana-Seisdedos F; Mogensen SC; Vuillier F; Fiers W; Virelizier JL
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6087-91. PubMed ID: 3137565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.